Product logins

Find logins to all Clarivate products below.


Skin Replacements and Substitutes | Market Insights | US | 2019

Although favorable demographics and the launch of innovative new products will drive continued growth in the US market for skin replacements and substitutes, challenges in the biologic product segment, with some private insurers ceasing to cover higher-priced amniotic allografts, will hinder market expansion to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for skin replacements and substitutes in the US across a 10-year period.

Related Medtech Insights Reports

Report
Skin Replacements and Substitutes – Market Insights – United States
The US skin replacements and substitutes market is expected to see gradual revenue growth. This growth will be driven by favorable demographics, increasing procedure volumes in nonhospital settings…
Report
Skin Replacements and Substitutes | Market Insights | US | 2023
Following the negative impact of the COVID-19 pandemic, the US skin replacement and substitute market will experience moderate revenue growth, supported by favorable demographics, the ongoing…
Report
Skin Replacements and Substitutes | Market Insights | US | 2022
The COVID-19 pandemic resulted in reduced procedure volumes, negatively impacting the US market for skin replacements and substitutes in the short term. However, after a period of recovery,…
Report
Skin Replacements and Substitutes | Market Insights | US | 2021
Although favorable demographics and the launch of innovative new products will drive continued growth in the US market for skin replacements and substitutes, challenges in the biologic product…
Report
Deep Venous Disease Treatment Devices | Market Insights | Global | 2020
The global market for deep venous disease treatment devices consists of a combination of the mature deep venous disease treatment thrombectomy and thrombolysis and PTA balloon catheter segments,…